Rethinking Cancer: Panel Discussion Session 3
Rethinking Cancer: Panel Discussion Session 3
Prof Mark Emberton, Dean UCL Medical Sciences
Prof Adrienne Flanagan OBE, UCL Cancer Institute
Dr Nora Pashayan, UCL Institute of Epidemiology & Health Care
Prof Caroline Moore, UCLH Trust
Prof Sam Janes, Wellcome Trust & UCL Respiratory
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
Cancer detection: the earlier the better?
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
Prof Adrienne Flanagan OBE, UCL Cancer Institute
Dr Nora Pashayan, UCL Institute of Epidemiology & Health Care
Prof Caroline Moore, UCLH Trust
Prof Sam Janes, Wellcome Trust & UCL Respiratory
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
Cancer detection: the earlier the better?
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.